Clinical Proof of Concept for an Innovative Inhaled Oxytocin Product to Address the Leading Cause of Global Maternal Mortality

McIntosh, Michelle (Primary Chief Investigator (PCI))
Lambert, Pete (Chief Investigator (CI))
Kirkpatrick, Carl (Chief Investigator (CI))
Palmer, Kirsten (Chief Investigator (CI))
Kruger, Nicole (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	1/01/21 → 31/12/21

Funding

Department of Jobs, Skills, Industry and Regions (DJSIR) (Victoria): A$438,156.00
Janssen Pharmaceutical (Yardley, Pennsylvania, United States of America): A$438,156.00